Concepedia

Susan Galbraith

SG

33

Publications

3.4K

Citations

24

H-Index

1996

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Mount Vernon Cancer Centre

AstraZeneca (United Kingdom)

Bristol-Myers Squibb (Germany)

Mount Vernon Hospital

Susan Galbraith is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1996–2023

33

Publications

33

Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

Susan Galbraith, Martin A. Lodge, N. Jane Taylor et al. · NMR in Biomedicine · 2002 · 339 citations · Full text

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging

Susan Galbraith, Ross J. Maxwell, Martin A. Lodge et al. · Journal of Clinical Oncology · 2003 · 325 citations

Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results

Gordon Rustin, Susan Galbraith, Helén Anderson et al. · Journal of Clinical Oncology · 2003 · 307 citations

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · Oxford University Research Archive (ORA) (University of Oxford) · 2002 · 231 citations

, , +17

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

David M. Berman, Susan Parker, Jonathan Siegel et al. · PubMed · 2010 · 227 citations · Full text

, , +22

Rows per page

1–5 of 33